Palo Alto, CA – June 30, 2009 – Conformia Software, an enterprise software company that manages the drug development lifecycle environment from initial candidate selection through to commercial launch and manufacture, has announced the sale of its intellectual property assets to Oracle Corporation, the world’s largest enterprise software company. Conformia’s Product and Process Lifecycle Management (PPLM) software manages drug design, development, and transfer to production across Bio, Pharmaceutical and Chemical drug components for Life Sciences companies.
The acquisition will allow Pharmaceutical and Bio-technology companies to fast-track innovation, maintain compliance, and improve efficiency. Conformia’s products and technologies will be integrated into Oracle Agile PLM solution, creating an end-to-end solution for managing drug development, packaging, and commercialization. Additionally, Oracle will provide integrations to Oracle applications, Oracle Health Sciences applications, and 3rd party systems.
“The addition of Conformia Software technology underscores Oracle’s commitment to provide customers with a differentiated, out-of-box industry-based solution. Oracle’s PLM offering will give our Life Sciences industry customers a complete solution to manage drug design, development to commercialization.” – Hardeep Gulati, VP of PLM Strategy, Oracle Corp.
Woodside Capital Partners served as the exclusive financial advisor to Conformia Software in this transaction.
About Conformia Software
Conformia is the first enterprise software company dedicated to addressing the unique challenges of managing the drug development lifecycle environment from initial candidate selection through to commercial launch and manufacture.
This enterprise software has been derived from many years of partnership with industry in order to understand and encapsulate the key business requirements combined with the scientific and regulatory drivers of the development organization.
Conformia is a leader in the Product and Process Lifecycle management for the highly regulated process industry such as Life Sciences, Alcohol & Beverages, etc.
About Oracle Corporation
Oracle (NASDAQ: ORCL) is the world’s largest enterprise software company. The Oracle Cloud offers complete SaaS application suites for ERP, HCM and CX, plus best-in-class database Platform as a Service (PaaS) and Infrastructure as a Service (IaaS) from data centers throughout the Americas, Europe and Asia. For more information about Oracle (NYSE:ORCL), please visit us at www.oracle.com.
About Woodside Capital Partners
Woodside Capital Partners is a global, independent investment bank that delivers world-class strategic and financial advice to emerging growth companies in the technology and life sciences sectors. With a strong track record in M&A, strategic partnerships and private placements, Woodside Capital Partners has been providing worldwide investment banking services since 2001, with leading domain experience in software, Internet services, electronic communications and materials, and healthcare. Woodside Capital Partners is headquartered in Silicon Valley, with an office in London. Securities offered through Woodside Capital Securities LLC, member FINRA/SIPC. For more information, please visit www.woodsidecap.com.